𝕔ALL #𝕘IRLS Service in Jaipur %(8901183002)# Jaipur #𝕔ALL #𝕘IRLS
Covid-19 (SARS-CoV-2) from Pathophysiology to Vaccine Development.
1. SARS-CoV-2 from Pathophysiology to
Vaccine Development
By
Arindam Sain
(CSIR- JRF, Department of Biotechnology, MAKAUT, W.B.)
PHYSIOLOGY NEWS
2. CORONA Virus
Order- Nidovirales
Family- Coronaviridae
Genus- b-coronavirus
Pathogenetic and Zoonotic in nature
A spherical particle with crown like projection
Average diameter- 125nM
Viral envelope consists of lipid bilayer with anchored
proteins
Nucleocapsid- N protein with positive sense single
stranded RNA genome
PHYSIOLOGY NEWS
3. 4 major structural proteins-
• Spike (S) protein
• Nucleocapsid (N) protein
• Membrane (M) protein
• The envelope (E) protein
Wrapp et al. , 2020
PHYSIOLOGY NEWS
4. THE LIFE CYCLE OF SARS-CoV-2 IN HOST CELLS
1. S protein binds to the cellular receptor ACE2
2. Conformation change in the S protein facilitates viral envelope
fusion with the cell membrane
3. SARS-CoV-2 releases RNA into the host cell
4. Genome RNA is translated into viral replicase polyproteins pp1a and
1ab
5. Cleavage into small products by viral proteinases
6. The polymerase produces a series of sub-genomic mRNAs by
discontinuous transcription
7. Translation into relevant viral proteins
8. Viral proteins and genome RNA are subsequently assembled into
virions in the ER and Golgi
9. Transportion via vesicles and released out of the cell
PHYSIOLOGY NEWS
6. After incubation period, virus causes non-
severe symptoms and elicits protective immune
responses
Successful elimination of the infection relies on
the individual’s health status and the HLA
haplotype
If the general health status and the HLA
haplotype of the infected individual do not
eliminate the virus, the patient then enters the
severe stage, when strong damaging
inflammatory response occurs, especially in the
lungs.
At this stage, inhibition of hyaluronan synthase
and elimination of hyaluronan can be
prescribed.
Cytokine activated mesenchymal stem cells
can be used to block inflammation and promote
tissue reparation.Yufang Shi et al., 2020
PROGRESSION OF COVID-19 INFECTION AND POTENTIAL ADJUVANT
INTERVENTIONS
8. IMBALANCED HOST RESPONSE TO SARS-CoV-2
DRIVES DEVELOPMENT OF COVID-19
SARS-CoV-2 infection induces
low IFN-I and -III levels with a
moderate ISG response
Strong chemokine expression is
consistent
across in vitro, ex vivo,
and in vivo models
Low innate antiviral defenses
and high pro-inflammatory cues
contribute to COVID-19
Daniel Blanco-Melo et al., 2020
PHYSIOLOGY NEWS
9. SCHEMATIC REPRESENTATION OF SARS-CoV-2-driven SIGNALLING
PATHWAYS AND POTENTIAL DRUG TARGETS.
Michele Catanzaro et al., 2020
PHYSIOLOGY NEWS
11. HYPOTHETICAL MECHANISM BY SARS-CoV-2 IN ESTABLISHING AN
INFLAMMATORY FEEDBACK LOOP BETWEEN IL-6 AND
ANGIOTENSIN II
Michele Catanzaro et al., 2020PHYSIOLOGY NEWS
12. POSSIBLE PATHWAYS CONTRIBUTING TO HYPERACTIVATION OF
MONOCYTE-DERIVED MACROPHAGES AND HYPERINFLAMMATION
IN COVID-19
Miriam Merad and Jerome C. Martin, 2020PHYSIOLOGY NEWS
13. Possible contribution of hyperactivated monocytes to
coagulation in COVID-19
Miriam Merad and Jerome C. Martin, 2020
PHYSIOLOGY NEWS
15. Trained immunity is defined as an
enhanced innate immune response to
different pathogens after an initial
challenge, such as vaccination or infection.
Certain microbial ligands capable of
binding specific pattern recognition
receptors are able to induce durable
metabolic and epigenetic changes in innate
immune cells. This reprogramming of the
metabolic and epigenetic landscape of the
cell allows quick accessibility of
transcription factors to the promoter and
enhancer regions of pro-inflammatory
genes upon restimulation, facilitating gene
expression. The increased metabolic
activity of the cell affords fast supply of the
energy and metabolites necessary to mount
a robust immune response upon
restimulation. Combination of these
epigenetic and metabolic effects affords
increased responsiveness upon secondary
stimulation with the same or a different
ligand and can even protect against a
subsequent infection.
Trained Immunity Mechanisms and Improvement of Anti-
viral Host Defense
Cell 181, May 28, 2020 PHYSIOLOGY NEWS
16. Trained Immunity Can Be Used to Prevent the
Spread of New Infections
Cell 181, May 28, 2020PHYSIOLOGY NEWS
17. Meta-analysis of human, non-
human primate, and mouse
single-cellRNA-seq datasets for
putativeSARS-CoV-2 targets
Type II pneumocytes, nasal
secretory cells, and absorptive
enterocytes are ACE2+TMPRSS2+
Interferon and influenza increase
ACE2 in human nasal epithelia
and lung tissue
Mouse Ace2 is not upregulated by
interferon, raising implications for
disease modelling
Ziegler et al., 2020, Cell 181, 1016–1035
PHYSIOLOGY NEWS
18. DEVELOPING VACCINES AND THERAPEUTIC
ANTIBODIES FOR COVID-19
Sempowski et al., 2020
PHYSIOLOGY NEWS
24. Potential therapeutic effects of
MSCs in respiratory lung injury
are mediated by different
mechanisms including but not
limited to secreted paracrine
factors, extracellular vesicles
(EVs), and possibly mitochondrial
transfer, promoting tissue
protection, immunomodulation,
and possibly viral resistance.
Khoury et al., 2020
PHYSIOLOGY NEWS
26. STEM CELLS IN COVID-19 - FROM A TARGET FOR VIRAL
INFECTION TO THERAPY WITH MESENCHYMAL STEM
CELLS (MSC)
Stem Cell Rev and Rep (2020) 16:434–440PHYSIOLOGY NEWS
27. POSSIBLE IMPACT OF HEPARIN IN
COVID-19
J Thromb Haemost. 2020;18:1020–1022.
PHYSIOLOGY NEWS
29. PATHOGENESIS OF COVID-19 AND POTENTIAL
ADJUVANT USE OF MELATONIN.
R. Zhang, et al., 2020PHYSIOLOGY NEWS
30. NATURAL PRODUCTS MAY INTERFERE WITH SARS-COV-2
ATTACHMENT TO THE HOST CELL
A. A. ELFIKY., 2020
PHYSIOLOGY NEWS
31. THANK YOU
To be continued..
PHYSIOLOGY NEWS
https://www.facebook.com/physiologynews2013/
physiologynews@gmail.com
https://www.instagram.com/physiologynews2013/